Skip to content

Application of urine complement protein detection system based on targeted proteomics quantitative technology in diagnosis and follow-up of IgA nephropathy

Application of urine complement protein detection system based on targeted proteomics quantitative technology in diagnosis and follow-up of IgA nephropathy

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120599
Enrollment
Unknown
Registered
2026-03-17
Start date
2024-08-01
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IgA nephropathy

Interventions

Chronic glomerulonephritis: hematuria with proteinuria (24h urinary protein quantity = 60ml/min
:None
Macroproteinuria: macroproteinuria (24h urinary protein quantity >= 1 g/d), GFR >= 60ml/min
Healthy control group:None

Sponsors

Hangzhou Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age: 16-75 years old, gender not limited. 2. Patients diagnosed with IgAN through renal biopsy during their hospitalization in our hospital. The pathological results need to be diagnosed jointly by two experienced pathologists. 3. GFR (EPI formula) =45 ml/min/1.73 m^2 4. All patients signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. There are severe primary diseases of the heart, brain, liver, hematopoietic system, etc. 2. Patients with secondary IgAN (such as purpura nephritis, hepatitis B-related nephritis, rheumatic diseases, etc.) and those with IgAN complicated with other kidney diseases; 3. Diabetes; 4. Patients who have recently been accompanied by severe infections or acute renal function impairment. 5. Patients who have used hormones and immunosuppressants in the past three months. 6. Pregnant and lactating women. Any of the following circumstances shall be excluded.

Design outcomes

Primary

MeasureTime frame
Urine complement;Immunofluorescence staining of complement associated protein in renal tissue;

Secondary

MeasureTime frame
Urine specific gravity;Urinary protein;Urine red blood cell;Urine protein-creatinine ratio;24h urinary protein;Blood routine;Serum creatinine;Blood urea nitrogen;Blood lipid;ImmunoglobulinG/A/M;Complement C3/C4;Glomerular filtration rate;

Countries

China

Contacts

Public ContactJiang Xue

Hangzhou Hospital of Traditional Chinese Medicine

monica_jiang@163.com+86 159 5817 0363

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026